Loading…

Twelve-year survival of the first living-donor pediatric lung transplantation in Brazil

To report the long-term follow-up of the first living-donor lobar lung transplantation performed in Latin America. The patient was a 12-year-old boy with post-infectious obliterative bronchiolitis with end-stage pulmonary disease. He was on continuous oxygen support, presenting with dyspnea even dur...

Full description

Saved in:
Bibliographic Details
Published in:Jornal de pediatria 2012-09, Vol.88 (5), p.413-416
Main Authors: Machuca, Tiago Noguchi, Sidney Filho, Luzielio Alves, Schio, Sadi Marcelo, Camargo, Spencer Marcantonio, Felicetti, José Carlos, Camargo, José Jesus Peixoto
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 416
container_issue 5
container_start_page 413
container_title Jornal de pediatria
container_volume 88
creator Machuca, Tiago Noguchi
Sidney Filho, Luzielio Alves
Schio, Sadi Marcelo
Camargo, Spencer Marcantonio
Felicetti, José Carlos
Camargo, José Jesus Peixoto
description To report the long-term follow-up of the first living-donor lobar lung transplantation performed in Latin America. The patient was a 12-year-old boy with post-infectious obliterative bronchiolitis with end-stage pulmonary disease. He was on continuous oxygen support, presenting with dyspnea even during minimal activity. He underwent bilateral lobar lung transplantation with living donors. The procedure was performed with the left and right lower lobes of two different related donors. In the second side cardiopulmonary bypass was required. The transplant was uneventful, and the patient was extubated after 14 hours and discharged with 44 days, after resolution of infectious, immunological and drug-related complications. After 12 years of follow-up, he presents with adequate lung function and has resumed his habitual activities. Living-donor lobar lung transplantation is a complex procedure feasible for the treatment of selected pediatric end-stage pulmonary disease. This particular population might benefit from this approach since the availability of pediatric donors is very scarce and the clinical course of pediatric advanced pulmonary disease may be unpredictable.
doi_str_mv 10.2223/JPED.2222
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1115063369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1115063369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-83d5c64ad261c9f3a8d1463922c72f73c9533d50517348c4f5f76eb44bb18e403</originalsourceid><addsrcrecordid>eNo9kLtOwzAARS0EoqUw8APIIwwBv2I7I5TyUiUYihgjx7GLkZsEOwkqX0-iAtO9w9HV1QHgFKNLQgi9enpZ3I6N7IEp5kImTEiyD6YIEZyINBUTcBTjB0Ipzzg-BBNCEaFC8il4W30Z35tka1SAsQu965WHtYXtu4HWhdhC73pXrZOyruoAG1M61Qanoe-qNWyDqmLjVdWq1tUVdBW8Cerb-WNwYJWP5uQ3Z-D1brGaPyTL5_vH-fUy0USiNpG0TDVnqiQc68xSJUvMOM0I0YJYQXWW0gFBKRaUSc1sagU3BWNFgaVhiM7A-W63CfVnZ2Kbb1zUxg-XTN3FHGOcIk4pzwb0YofqUMcYjM2b4DYqbHOM8tFjPnocGxnYs9_ZrtiY8p_8E0d_AFasbUo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1115063369</pqid></control><display><type>article</type><title>Twelve-year survival of the first living-donor pediatric lung transplantation in Brazil</title><source>SciELO Brazil</source><creator>Machuca, Tiago Noguchi ; Sidney Filho, Luzielio Alves ; Schio, Sadi Marcelo ; Camargo, Spencer Marcantonio ; Felicetti, José Carlos ; Camargo, José Jesus Peixoto</creator><creatorcontrib>Machuca, Tiago Noguchi ; Sidney Filho, Luzielio Alves ; Schio, Sadi Marcelo ; Camargo, Spencer Marcantonio ; Felicetti, José Carlos ; Camargo, José Jesus Peixoto</creatorcontrib><description>To report the long-term follow-up of the first living-donor lobar lung transplantation performed in Latin America. The patient was a 12-year-old boy with post-infectious obliterative bronchiolitis with end-stage pulmonary disease. He was on continuous oxygen support, presenting with dyspnea even during minimal activity. He underwent bilateral lobar lung transplantation with living donors. The procedure was performed with the left and right lower lobes of two different related donors. In the second side cardiopulmonary bypass was required. The transplant was uneventful, and the patient was extubated after 14 hours and discharged with 44 days, after resolution of infectious, immunological and drug-related complications. After 12 years of follow-up, he presents with adequate lung function and has resumed his habitual activities. Living-donor lobar lung transplantation is a complex procedure feasible for the treatment of selected pediatric end-stage pulmonary disease. This particular population might benefit from this approach since the availability of pediatric donors is very scarce and the clinical course of pediatric advanced pulmonary disease may be unpredictable.</description><identifier>ISSN: 0021-7557</identifier><identifier>EISSN: 1678-4782</identifier><identifier>DOI: 10.2223/JPED.2222</identifier><identifier>PMID: 23023786</identifier><language>eng</language><publisher>Brazil</publisher><subject>Brazil ; Bronchiolitis Obliterans - therapy ; Child ; Humans ; Living Donors ; Lung Transplantation - standards ; Male ; Survivors ; Treatment Outcome</subject><ispartof>Jornal de pediatria, 2012-09, Vol.88 (5), p.413-416</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23023786$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Machuca, Tiago Noguchi</creatorcontrib><creatorcontrib>Sidney Filho, Luzielio Alves</creatorcontrib><creatorcontrib>Schio, Sadi Marcelo</creatorcontrib><creatorcontrib>Camargo, Spencer Marcantonio</creatorcontrib><creatorcontrib>Felicetti, José Carlos</creatorcontrib><creatorcontrib>Camargo, José Jesus Peixoto</creatorcontrib><title>Twelve-year survival of the first living-donor pediatric lung transplantation in Brazil</title><title>Jornal de pediatria</title><addtitle>J Pediatr (Rio J)</addtitle><description>To report the long-term follow-up of the first living-donor lobar lung transplantation performed in Latin America. The patient was a 12-year-old boy with post-infectious obliterative bronchiolitis with end-stage pulmonary disease. He was on continuous oxygen support, presenting with dyspnea even during minimal activity. He underwent bilateral lobar lung transplantation with living donors. The procedure was performed with the left and right lower lobes of two different related donors. In the second side cardiopulmonary bypass was required. The transplant was uneventful, and the patient was extubated after 14 hours and discharged with 44 days, after resolution of infectious, immunological and drug-related complications. After 12 years of follow-up, he presents with adequate lung function and has resumed his habitual activities. Living-donor lobar lung transplantation is a complex procedure feasible for the treatment of selected pediatric end-stage pulmonary disease. This particular population might benefit from this approach since the availability of pediatric donors is very scarce and the clinical course of pediatric advanced pulmonary disease may be unpredictable.</description><subject>Brazil</subject><subject>Bronchiolitis Obliterans - therapy</subject><subject>Child</subject><subject>Humans</subject><subject>Living Donors</subject><subject>Lung Transplantation - standards</subject><subject>Male</subject><subject>Survivors</subject><subject>Treatment Outcome</subject><issn>0021-7557</issn><issn>1678-4782</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNo9kLtOwzAARS0EoqUw8APIIwwBv2I7I5TyUiUYihgjx7GLkZsEOwkqX0-iAtO9w9HV1QHgFKNLQgi9enpZ3I6N7IEp5kImTEiyD6YIEZyINBUTcBTjB0Ipzzg-BBNCEaFC8il4W30Z35tka1SAsQu965WHtYXtu4HWhdhC73pXrZOyruoAG1M61Qanoe-qNWyDqmLjVdWq1tUVdBW8Cerb-WNwYJWP5uQ3Z-D1brGaPyTL5_vH-fUy0USiNpG0TDVnqiQc68xSJUvMOM0I0YJYQXWW0gFBKRaUSc1sagU3BWNFgaVhiM7A-W63CfVnZ2Kbb1zUxg-XTN3FHGOcIk4pzwb0YofqUMcYjM2b4DYqbHOM8tFjPnocGxnYs9_ZrtiY8p_8E0d_AFasbUo</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Machuca, Tiago Noguchi</creator><creator>Sidney Filho, Luzielio Alves</creator><creator>Schio, Sadi Marcelo</creator><creator>Camargo, Spencer Marcantonio</creator><creator>Felicetti, José Carlos</creator><creator>Camargo, José Jesus Peixoto</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120901</creationdate><title>Twelve-year survival of the first living-donor pediatric lung transplantation in Brazil</title><author>Machuca, Tiago Noguchi ; Sidney Filho, Luzielio Alves ; Schio, Sadi Marcelo ; Camargo, Spencer Marcantonio ; Felicetti, José Carlos ; Camargo, José Jesus Peixoto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-83d5c64ad261c9f3a8d1463922c72f73c9533d50517348c4f5f76eb44bb18e403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Brazil</topic><topic>Bronchiolitis Obliterans - therapy</topic><topic>Child</topic><topic>Humans</topic><topic>Living Donors</topic><topic>Lung Transplantation - standards</topic><topic>Male</topic><topic>Survivors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Machuca, Tiago Noguchi</creatorcontrib><creatorcontrib>Sidney Filho, Luzielio Alves</creatorcontrib><creatorcontrib>Schio, Sadi Marcelo</creatorcontrib><creatorcontrib>Camargo, Spencer Marcantonio</creatorcontrib><creatorcontrib>Felicetti, José Carlos</creatorcontrib><creatorcontrib>Camargo, José Jesus Peixoto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Jornal de pediatria</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Machuca, Tiago Noguchi</au><au>Sidney Filho, Luzielio Alves</au><au>Schio, Sadi Marcelo</au><au>Camargo, Spencer Marcantonio</au><au>Felicetti, José Carlos</au><au>Camargo, José Jesus Peixoto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Twelve-year survival of the first living-donor pediatric lung transplantation in Brazil</atitle><jtitle>Jornal de pediatria</jtitle><addtitle>J Pediatr (Rio J)</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>88</volume><issue>5</issue><spage>413</spage><epage>416</epage><pages>413-416</pages><issn>0021-7557</issn><eissn>1678-4782</eissn><abstract>To report the long-term follow-up of the first living-donor lobar lung transplantation performed in Latin America. The patient was a 12-year-old boy with post-infectious obliterative bronchiolitis with end-stage pulmonary disease. He was on continuous oxygen support, presenting with dyspnea even during minimal activity. He underwent bilateral lobar lung transplantation with living donors. The procedure was performed with the left and right lower lobes of two different related donors. In the second side cardiopulmonary bypass was required. The transplant was uneventful, and the patient was extubated after 14 hours and discharged with 44 days, after resolution of infectious, immunological and drug-related complications. After 12 years of follow-up, he presents with adequate lung function and has resumed his habitual activities. Living-donor lobar lung transplantation is a complex procedure feasible for the treatment of selected pediatric end-stage pulmonary disease. This particular population might benefit from this approach since the availability of pediatric donors is very scarce and the clinical course of pediatric advanced pulmonary disease may be unpredictable.</abstract><cop>Brazil</cop><pmid>23023786</pmid><doi>10.2223/JPED.2222</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-7557
ispartof Jornal de pediatria, 2012-09, Vol.88 (5), p.413-416
issn 0021-7557
1678-4782
language eng
recordid cdi_proquest_miscellaneous_1115063369
source SciELO Brazil
subjects Brazil
Bronchiolitis Obliterans - therapy
Child
Humans
Living Donors
Lung Transplantation - standards
Male
Survivors
Treatment Outcome
title Twelve-year survival of the first living-donor pediatric lung transplantation in Brazil
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A12%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Twelve-year%20survival%20of%20the%20first%20living-donor%20pediatric%20lung%20transplantation%20in%20Brazil&rft.jtitle=Jornal%20de%20pediatria&rft.au=Machuca,%20Tiago%20Noguchi&rft.date=2012-09-01&rft.volume=88&rft.issue=5&rft.spage=413&rft.epage=416&rft.pages=413-416&rft.issn=0021-7557&rft.eissn=1678-4782&rft_id=info:doi/10.2223/JPED.2222&rft_dat=%3Cproquest_cross%3E1115063369%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c280t-83d5c64ad261c9f3a8d1463922c72f73c9533d50517348c4f5f76eb44bb18e403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1115063369&rft_id=info:pmid/23023786&rfr_iscdi=true